Gujarat Inject Kerala Ltd Stock Price Today (NSE: GUJINJEC)
Fundamental Score
Gujarat Inject Kerala Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Gujarat Inject Kerala Ltd share price today is ₹78.21, up +0.68% on NSE/BSE as of 30 March 2026. Gujarat Inject Kerala Ltd (GUJINJEC) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹41.42 (Cr). The 52-week high for GUJINJEC share price is ₹75.48 and the 52-week low is ₹17.02. At a P/E ratio of 98.61x, GUJINJEC is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 11.00% and a debt-to-equity ratio of 0.00.
Gujarat Inject Kerala Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Gujarat Inject Kerala Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Gujarat Inject Kerala Share Price Analysis: A ROCE-Focused Perspective
In the dynamic pharmaceutical sector, characterized by evolving regulatory landscapes and intense competition, Return on Capital Employed (ROCE) emerges as a pivotal metric for assessing operational efficiency and long-term sustainability. This analysis delves into the Gujarat Inject Kerala share price, currently at ₹53.93, focusing on its ROCE performance and its implications for the company's competitive positioning. Our fundamental audit, a subset of a comprehensive 80-parameter assessment, is verified by Sweta Mishra.
Gujarat Inject Kerala Ltd reports a ROCE of 13.48%. This figure provides insights into how effectively the company is using its capital to generate profits. A higher ROCE generally indicates superior capital allocation and operational efficiency. However, it's crucial to evaluate this figure in the context of its peers and historical performance.
Comparing Gujarat Inject Kerala Ltd to its peers provides a richer understanding of its relative performance.
Mankind Pharma Ltd, for example, might command a premium valuation due to factors beyond just financial metrics, such as perceived superior management quality and brand equity. While a direct comparison of management effectiveness requires deeper qualitative analysis, it is undeniable that factors influencing perception significantly sway valuations.The 13.48% ROCE plays a crucial role in shaping the company’s "moat," or its sustainable competitive advantage. A consistent and healthy ROCE suggests that Gujarat Inject Kerala Ltd possesses factors allowing it to earn returns above its cost of capital. This could stem from factors such as economies of scale, proprietary technology, or strong customer relationships. Over time, a strong ROCE can enable the company to reinvest in its business, further solidifying its market position and creating a virtuous cycle of growth and profitability. However, sustainability requires continued innovation and adaptation to market dynamics.
Further analysis should involve benchmarking Gujarat Inject Kerala Ltd against other peers, such as Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, to understand the sector-specific ROCE landscape. A deeper dive into the company's financials is also needed to discern the drivers behind the ROCE, including its operating margin and capital turnover. This allows for a more comprehensive understanding of the factors influencing the Gujarat Inject Kerala share price and its potential future performance.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Gujarat Inject Kerala Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GUJINJEC across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Excellent EPS Growth (104.89% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Margin Pressure Concerns (2.32%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 98.61x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-88.52%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-81.65%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Negative Free Cash Flow (₹-9.61 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Gujarat Inject Kerala Ltd Financial Statements
Comprehensive financial data for Gujarat Inject Kerala Ltd including income statement, balance sheet and cash flow
About GUJINJEC (Gujarat Inject Kerala Ltd)
Gujarat Inject Kerala Ltd is a dynamic pharmaceutical entity making significant strides in the Indian healthcare landscape. Rooted in a commitment to quality and innovation, the co...mpany diligently sources and distributes a wide array of pharmaceutical products, catering to diverse therapeutic needs. With a strong emphasis on ethical practices and regulatory compliance, GUJINJEC strives to ensure that patients and healthcare professionals have access to reliable and effective medications. Their extensive network and strategic partnerships enable them to efficiently navigate the complexities of the pharmaceutical supply chain, ensuring timely delivery and consistent availability of vital medicines. The company's operations are characterized by a customer-centric approach, focusing on building strong relationships with pharmacies, hospitals, and medical practitioners. GUJINJEC's dedicated team works tirelessly to understand the evolving needs of the market and respond proactively with tailored solutions. This dedication extends beyond mere product distribution; they aim to provide comprehensive support to their partners, fostering a collaborative environment that promotes better patient outcomes. By staying abreast of the latest advancements in pharmaceutical research and technology, GUJINJEC endeavors to contribute to the overall improvement of healthcare standards in India. Operating from its base in Vadodara, India, GUJINJEC leverages its strategic location to efficiently manage its nationwide distribution network. The company maintains a robust infrastructure and adheres to stringent quality control measures throughout its operations. Furthermore, GUJINJEC is committed to sustainable business practices, actively seeking opportunities to minimize its environmental impact and contribute to the well-being of the communities it serves. The company’s unwavering focus on integrity, quality, and customer satisfaction positions it as a trusted and reliable partner in the Indian pharmaceutical industry.
Company Details
Key Leadership
GUJINJEC Share Price: Frequently Asked Questions
What is the current share price of Gujarat Inject Kerala Ltd (GUJINJEC)?
As of 30 Mar 2026, 12:02 pm IST, Gujarat Inject Kerala Ltd share price is ₹78.21. The GUJINJEC stock has a market capitalisation of ₹41.42 (Cr) on NSE/BSE.
Is GUJINJEC share price Overvalued or Undervalued?
GUJINJEC share price is currently trading at a P/E ratio of 98.61x, compared to the industry average of 31.77x. Based on this relative valuation, the Gujarat Inject Kerala Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of GUJINJEC share price?
The 52-week high of GUJINJEC share price is ₹75.48 and the 52-week low is ₹17.02. These values are updated daily from NSE/BSE price data.
What factors affect the Gujarat Inject Kerala Ltd share price?
Key factors influencing GUJINJEC share price include quarterly earnings growth (Sales Growth: -81.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gujarat Inject Kerala Ltd a good stock for long-term investment?
Gujarat Inject Kerala Ltd shows a 5-year Profit Growth of N/A% and an ROE of 11.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in GUJINJEC shares.
How does Gujarat Inject Kerala Ltd compare with its industry peers?
Gujarat Inject Kerala Ltd competes with major peers in the Pharmaceuticals. Investors should compare GUJINJEC share price P/E of 98.61x and ROE of 11.00% against the industry averages to determine competitive standing.
What is the P/E ratio of GUJINJEC and what does it mean?
GUJINJEC share price has a P/E ratio of 98.61x compared to the industry average of 31.77x. Investors pay ₹99 for every ₹1 of annual earnings.
How is GUJINJEC performing according to Bull Run's analysis?
GUJINJEC has a Bull Run fundamental score of 12.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GUJINJEC belong to?
GUJINJEC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gujarat Inject Kerala Ltd share price.
What is Return on Equity (ROE) and why is it important for GUJINJEC?
GUJINJEC has an ROE of 11.00%, which shows decent profitability but room for improvement. ROE measures how efficiently Gujarat Inject Kerala Ltd generates profits from shareholders capital.
How is GUJINJEC debt-to-equity ratio and what does it indicate?
GUJINJEC has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is GUJINJEC dividend yield and is it a good dividend stock?
GUJINJEC offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Gujarat Inject Kerala Ltd shares.
How has GUJINJEC share price grown over the past 5 years?
GUJINJEC has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth 104.89%.
What is the promoter holding in GUJINJEC and why does it matter?
Promoters hold 0.00% of GUJINJEC shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Gujarat Inject Kerala Ltd.
What is GUJINJEC market capitalisation category?
GUJINJEC has a market capitalisation of ₹41 crores, placing it in the Small-cap category.
How volatile is GUJINJEC stock?
GUJINJEC has a beta of N/A. A beta > 1 suggests the Gujarat Inject Kerala Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GUJINJEC operating profit margin trend?
GUJINJEC has a 5-year average Operating Profit Margin (OPM) of 2.32%, indicating the company's operational efficiency.
How is GUJINJEC quarterly performance?
Recent quarterly performance shows Gujarat Inject Kerala Ltd YoY Sales Growth of -81.65% and YoY Profit Growth of -88.52%.
What is the institutional holding pattern in GUJINJEC?
GUJINJEC has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Gujarat Inject Kerala Ltd stock.